Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

IL-17A Is Critical for CD8+ T Effector Response in Airway Epithelial Injury After Transplantation.

Zhang R, Fang H, Chen R, Ochando JC, Ding Y, Xu J.

Transplantation. 2018 Dec;102(12):e483-e493. doi: 10.1097/TP.0000000000002452.

PMID:
30211827
2.

Liver inflammation abrogates immunological tolerance induced by Kupffer cells.

Heymann F, Peusquens J, Ludwig-Portugall I, Kohlhepp M, Ergen C, Niemietz P, Martin C, van Rooijen N, Ochando JC, Randolph GJ, Luedde T, Ginhoux F, Kurts C, Trautwein C, Tacke F.

Hepatology. 2015 Jul;62(1):279-91. doi: 10.1002/hep.27793. Epub 2015 Apr 22.

PMID:
25810240
3.

Editorial: Dexamethasone and MDSC in transplantation: yes to NO.

Ochando JC, Conde P.

J Leukoc Biol. 2014 Nov;96(5):669-71. doi: 10.1189/jlb.3CE0514-272R. No abstract available.

PMID:
25360039
4.

Innate immune cell collaborations instigate transplant tolerance.

Ochando JC, Turnquist HR.

Am J Transplant. 2014 Nov;14(11):2441-3. doi: 10.1111/ajt.12912. Epub 2014 Oct 13. No abstract available.

5.

IL-23 activates innate lymphoid cells to promote neonatal intestinal pathology.

Chen L, He Z, Slinger E, Bongers G, Lapenda TLS, Pacer ME, Jiao J, Beltrao MF, Soto AJ, Harpaz N, Gordon RE, Ochando JC, Oukka M, Iuga AC, Chensue SW, Blander JM, Furtado GC, Lira SA.

Mucosal Immunol. 2015 Mar;8(2):390-402. doi: 10.1038/mi.2014.77. Epub 2014 Aug 27.

6.

Immune tolerance to tumor antigens occurs in a specialized environment of the spleen.

Ugel S, Peranzoni E, Desantis G, Chioda M, Walter S, Weinschenk T, Ochando JC, Cabrelle A, Mandruzzato S, Bronte V.

Cell Rep. 2012 Sep 27;2(3):628-39. doi: 10.1016/j.celrep.2012.08.006. Epub 2012 Sep 6.

7.

Myeloid-derived suppressor cells in transplantation and cancer.

Ochando JC, Chen SH.

Immunol Res. 2012 Dec;54(1-3):275-85. doi: 10.1007/s12026-012-8335-1. Review.

8.

Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation.

Hashimoto D, Chow A, Greter M, Saenger Y, Kwan WH, Leboeuf M, Ginhoux F, Ochando JC, Kunisaki Y, van Rooijen N, Liu C, Teshima T, Heeger PS, Stanley ER, Frenette PS, Merad M.

J Exp Med. 2011 May 9;208(5):1069-82. doi: 10.1084/jem.20101709. Epub 2011 May 2.

9.

Plasmacytoid dendritic cells in tolerance.

Gehrie E, Van der Touw W, Bromberg JS, Ochando JC.

Methods Mol Biol. 2011;677:127-47. doi: 10.1007/978-1-60761-869-0_9.

10.

Myeloid-derived suppressor cells: natural regulators for transplant tolerance.

Boros P, Ochando JC, Chen SH, Bromberg JS.

Hum Immunol. 2010 Nov;71(11):1061-6. doi: 10.1016/j.humimm.2010.08.001. Epub 2010 Aug 10. Review.

11.

Immunotherapy with myeloid cells for tolerance induction.

Rodriguez-García M, Boros P, Bromberg JS, Ochando JC.

Curr Opin Organ Transplant. 2010 Aug;15(4):416-21. doi: 10.1097/MOT.0b013e32833bcf5e. Review.

12.

Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice.

Garcia MR, Ledgerwood L, Yang Y, Xu J, Lal G, Burrell B, Ma G, Hashimoto D, Li Y, Boros P, Grisotto M, van Rooijen N, Matesanz R, Tacke F, Ginhoux F, Ding Y, Chen SH, Randolph G, Merad M, Bromberg JS, Ochando JC.

J Clin Invest. 2010 Jul;120(7):2486-96. doi: 10.1172/JCI41628. Epub 2010 Jun 14.

13.

c-Maf regulates IL-10 expression during Th17 polarization.

Xu J, Yang Y, Qiu G, Lal G, Wu Z, Levy DE, Ochando JC, Bromberg JS, Ding Y.

J Immunol. 2009 May 15;182(10):6226-36. doi: 10.4049/jimmunol.0900123.

14.

Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.

Zhang N, Schröppel B, Lal G, Jakubzick C, Mao X, Chen D, Yin N, Jessberger R, Ochando JC, Ding Y, Bromberg JS.

Immunity. 2009 Mar 20;30(3):458-69. doi: 10.1016/j.immuni.2008.12.022.

15.

The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics.

Ledgerwood LG, Lal G, Zhang N, Garin A, Esses SJ, Ginhoux F, Merad M, Peche H, Lira SA, Ding Y, Yang Y, He X, Schuchman EH, Allende ML, Ochando JC, Bromberg JS.

Nat Immunol. 2008 Jan;9(1):42-53. Epub 2007 Nov 25.

PMID:
18037890
16.

Identification of a distant T-bet enhancer responsive to IL-12/Stat4 and IFNgamma/Stat1 signals.

Yang Y, Ochando JC, Bromberg JS, Ding Y.

Blood. 2007 Oct 1;110(7):2494-500. Epub 2007 Jun 15.

17.

Sphingosine 1-phosphate receptor modulators: a new class of immunosuppressants.

Yopp AC, Ledgerwood LG, Ochando JC, Bromberg JS.

Clin Transplant. 2006 Nov-Dec;20(6):788-95. Review.

PMID:
17100731
18.
19.

Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts.

Ochando JC, Homma C, Yang Y, Hidalgo A, Garin A, Tacke F, Angeli V, Li Y, Boros P, Ding Y, Jessberger R, Trinchieri G, Lira SA, Randolph GJ, Bromberg JS.

Nat Immunol. 2006 Jun;7(6):652-62. Epub 2006 Apr 23.

PMID:
16633346
20.

Sphingosine 1-phosphate receptors regulate chemokine-driven transendothelial migration of lymph node but not splenic T cells.

Yopp AC, Ochando JC, Mao M, Ledgerwood L, Ding Y, Bromberg JS.

J Immunol. 2005 Sep 1;175(5):2913-24.

21.

Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells.

Ochando JC, Yopp AC, Yang Y, Garin A, Li Y, Boros P, Llodra J, Ding Y, Lira SA, Krieger NR, Bromberg JS.

J Immunol. 2005 Jun 1;174(11):6993-7005.

22.

Therapeutic manipulation of T cell chemotaxis in transplantation.

Yopp AC, Krieger NR, Ochando JC, Bromberg JS.

Curr Opin Immunol. 2004 Oct;16(5):571-7. Review.

PMID:
15342001

Supplemental Content

Loading ...
Support Center